Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Changes in Immunosuppressive Treatment of Chronic Graft-Versus-Host Disease: Results from a Survey within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland

Blood (2024) 144 (Supplement 1): 7334.

https://doi.org/10.1182/blood-2024-200375

Published: 2024

Journal Articles

Developing Evidence-Based Guidelines for Optimal Patient Communication Prior and Post Allogeneic Stem Cell Transplantation

Anne Herrmann, Helene Schoemans, Eva Wilhelm, Guy Tavori, Nada Hamad, Meredith A. Cowden, Anna Barata, Francis A. Ayuk, Wolfgang Herr, Joerg Halter, Stephanie Lee, Daniel Wolff

Blood (2024) 144 (Supplement 1): 4917.

https://doi.org/10.1182/blood-2024-199052

Published: 2024

Journal Articles

A National Platform and Scoring System Allocates CAR-T Treatment Slots for Multiple Myeloma to Patients with High Likelihood of Complete Remission

Christoph Driessen, Katharina Baur, Dominik Heim, Sabine Gerull, Christoph Renner, Anne Cairoli, Thomas Pabst, Joerg Halter, Michael Gregor, Nicole Graf, Nino Fejzibegovic, Nathan Wolfensberger, Federico Simonetta, Martin Fehr, Esteban Ciliberti, Rouven Müller, Barbara Jeker

Blood (2023) 142 (Supplement 1): 4701.

https://doi.org/10.1182/blood-2023-182628

Published: 2023

Journal Articles

An ounce of which prevention is worth a…?

Joerg Halter, Jakob Passweg

Blood (2021) 137 (14): 1852–1853.

https://doi.org/10.1182/blood.2021010688

Published: 2021

Journal Articles

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Andreas S. Buser, MD, Laura Infanti, MD, Andreas Holbro, MD, Joerg Halter, MD, Sabine Gerull, MD, Dominik Heim, MD, Michael Medinger, MD, Dimitrios A. Tsakiris, MD, Johannes Irsch, PhD, Jin-Sying Lin, PhD, Richard J. Benjamin, MD, Laurence Corash, MD, Jakob R. Passweg, MD

Blood (2019) 134 (Supplement_1): 1167.

https://doi.org/10.1182/blood-2019-122330

Published: 2019

Journal Articles

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Astrid Beerlage, MD, Joerg Halter, MD, Sabine Gerull, MD, Michael Medinger, MD, Tanja Ruefli, Georg Stussi, MD, Dominik Heim, MD, Beatrice Drexler, MD, Laura Infanti, MD, Andreas Holbro, MD, Jakob R. Passweg, MDMS, Andreas S. Buser, MD

Blood (2018) 132 (Supplement 1): 2551.

https://doi.org/10.1182/blood-2018-99-116237

Published: 2018

Journal Articles

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Ajib Salem, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Penter Livius, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, MD, Michael Lübbert, MD, Ralph Wäsch, MD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Omid Shah, MD, Robert S. Negrin, MD, Mats Brune, MD PhD, Alexandros Spyridonidis, MD PhD, Annette Schmitt-Graeff, MD, Walter J.F.M. van der Velden, MD PhD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MD PhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Jakob R. Passweg, Joerg Halter, MD, Gérard Socié, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Christian Peschel, MD, Andreas Neubauer, Jürgen Finke, Justus Duyster, MD, Nikolas von Bubnoff, MD

Blood (2016) 128 (22): 4561.

https://doi.org/10.1182/blood.V128.22.4561.4561

Published: 2016

Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD

Blood (2015) 126 (23): 858.

https://doi.org/10.1182/blood.V126.23.858.858

Published: 2015

Journal Articles

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Blood (2013) 122 (24): 3863–3870.

https://doi.org/10.1182/blood-2013-07-514448

Published: 2013

Journal Articles

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Philippe Armand, MD, PhD, Waleska Perez, MPH, Mei-Jie Zhang, PhD, Haesook Kim, PhD, Thomas R. Klumpp, MD, Paola Dal Cin, PhD, Edmund K Waller, MD, PhD, Mark R. Litzow, MD, Jane L. Liesveld, MD, Hillard M. Lazarus, MD, FACP, Andrew Artz, MD, MS, Vikas Gupta, MD, MRCP, FRCPath, Bipin N. Savani, MD, Philip L. McCarthy, MD, Jean-Yves Cahn, MD, Harry Schouten, Jurgen Finke, MD, Edward D. Ball, MD, Mahmoud Aljurf, MD, Corey Cutler, MD, MPH, FRCPC, Jacob M. Rowe, Joseph H. Antin, MD, Luis M Isola, MD, Paolo Di Bartolomeo, MD, Bruce Camitta, MD, Alan M Miller, MD, PhD, Mitchell S. Cairo, MD, Keith E. Stockerl-Goldstein, MD, Jorge Sierra, MD, Mary Lynn Savoie, MD, FRCPC, Joerg Halter, MD, Patrick J Stiff, MD, Chadi Nabhan, MD, FACP, Ann A. Jakubowski, MD, PhD, Donald Bunjes, MD, Effie W. Petersdorf, MD, Steven M Devine, MD, Richard Maziarz, MD, Martin Bornhauser, MD, Victor A Lewis, MD, David I. Marks, MBBS, PHD, Christopher N Bredeson, MD, MSc, FRCPC, Robert Soiffer, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 680.

https://doi.org/10.1182/blood.V116.21.680.680

Published: 2010

Journal Articles

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia in first and second complete remission

David I. Marks, Tao Wang, Waleska S. Pérez, Joseph H. Antin, Edward Copelan, Robert Peter Gale, Biju George, Vikas Gupta, Joerg Halter, H. Jean Khoury, Thomas R. Klumpp, Hillard M. Lazarus, Victor A. Lewis, Philip McCarthy, David A. Rizzieri, Mitchell Sabloff, Jeff Szer, Martin S. Tallman, Daniel J. Weisdorf

Blood (2010) 116 (3): 366–374.

https://doi.org/10.1182/blood-2010-01-264077

Published: 2010

Includes: Supplemental data

Journal Articles

The Bidirectional Relationship Between Cytomegalovirus Replication and Graft-Versus-Host Disease - a Retrospective Single Center Study.

Nathan Cantoni, Hans H Hirsch, Nina Khanna, Dominik Heim, Joerg Halter, Dimitrios Tsakiris, Christoph Bucher, Alicia Rovò, Caroline Arber, MD, Andreas S Buser, Andre Tichelli, Alois Gratwohl, Martin Stern

Blood (2009) 114 (22): 2236.

https://doi.org/10.1182/blood.V114.22.2236.2236

Published: 2009

Journal Articles

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

Joerg Halter, WM Michael Schuepbach, Carlo Casali, Ronit Elhasid, Keith Fay, Simon Hammans, Isabel Illa, Liliane Kappeler, Stephan Kraehenbuehl, Thomas Lehmann, Hanna Mandel, Ramon Marti, Heinrich Mattle, Kim H. Orchard, David Savage, Carolyn Sue, David Valcárcel, Alois Gratwohl, Michio Hirano

Blood (2009) 114 (22): 1181.

https://doi.org/10.1182/blood.V114.22.1181.1181

Published: 2009

Journal Articles

High-Dose Melphalan Re-Induction with or without Stem Cell Support Prior to Myeloablative Allogeneic Stem Cell Transplantation in Patients with Advanced Relapsed or Refractory Acute Myeloid Leukemia.

Alix O'Meara, MD, Thomas Pabst, MD, Dominik Heim, MD, Christoph Bucher, MD, Joerg Halter, MD, Caroline Arber, MD, Alicia Rovò, André Tichelli, MD, Alois Gratwohl, MD, Martin Stern, MD

Blood (2009) 114 (22): 2271.

https://doi.org/10.1182/blood.V114.22.2271.2271

Published: 2009

Journal Articles

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

Nathan Cantoni, Sabine Gerull, Dominik Heim, Joerg Halter, Dimitrios Tsakiris, Christoph Bucher, Alicia Rovo, Caroline Arber, Andreas S. Buser, Jakob R. Passweg, Andre Tichelli, Martin Stern, Alois Gratwohl

Blood (2009) 114 (22): 2268.

https://doi.org/10.1182/blood.V114.22.2268.2268

Published: 2009

Journal Articles

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

Sabine Gerull, MD, Joerg Halter, Christoph Bucher, Dominik Heim, MD, André Tichelli, MD, Alois Gratwohl, MD, Martin Stern, MD

Blood (2009) 114 (22): 3337.

https://doi.org/10.1182/blood.V114.22.3337.3337

Published: 2009

Journal Articles

Common Myeloid Progenitor Content in Allogeneic Graft Products Correlates with Time to Platelet Engraftment.

Caroline Arber, Joerg Halter, Martin Stern, Dominik Heim Alicia Rovò, Alois Gratwohl, Andre Tichelli

Blood (2009) 114 (22): 3215.

https://doi.org/10.1182/blood.V114.22.3215.3215

Published: 2009

Journal Articles

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Alicia Rovo, MD, Thomas Daikeler, MD, Joerg Halter, MD, Dominik Heim, MD, Jan Dirk Studt, MD, Michael Medinger, MD, Caroline Arber, MD, Martin Stern, MD, Dimitrios Tsakiris, MD, Alan Tyndall, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2008) 112 (11): 4298.

https://doi.org/10.1182/blood.V112.11.4298.4298

Published: 2008

Journal Articles

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

Antonio M. Risitano, MD, PhD, Elisa Seneca, Ludovica Marando, Bianca Serio, Carmine Selleri, Giulia Scalia, Luigi Del Vecchio, MD, Annapaola Iori, M.D., Alexander Kulagin, Sebastien Maury, Joerg Halter, Vikas Gupta, MD, MRCP, MRCPath, Andrea Bacigalupo, MD, Gerard Socié, Andre Tichelli, Judith Marsh, Hubert Schrezenmeier, Jakob R. Passweg, MD, MS, Bruno Rotoli

Blood (2008) 112 (11): 1042.

https://doi.org/10.1182/blood.V112.11.1042.1042

Published: 2008

Journal Articles

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

Blood (2008) 112 (8): 3500–3507.

https://doi.org/10.1182/blood-2008-02-141689

Published: 2008

Includes: Supplemental data

NARROW

Changes in Immunosuppressive Treatment of Chronic Graft-Versus-Host Disease: Results from a Survey within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland

Developing Evidence-Based Guidelines for Optimal Patient Communication Prior and Post Allogeneic Stem Cell Transplantation

A National Platform and Scoring System Allocates CAR-T Treatment Slots for Multiple Myeloma to Patients with High Likelihood of Complete Remission

An ounce of which prevention is worth a…?

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia in first and second complete remission

The Bidirectional Relationship Between Cytomegalovirus Replication and Graft-Versus-Host Disease - a Retrospective Single Center Study.

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

High-Dose Melphalan Re-Induction with or without Stem Cell Support Prior to Myeloablative Allogeneic Stem Cell Transplantation in Patients with Advanced Relapsed or Refractory Acute Myeloid Leukemia.

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

Common Myeloid Progenitor Content in Allogeneic Graft Products Correlates with Time to Platelet Engraftment.

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only